Company news
Chemclin Diagnostics Co., Ltd. Class A (SSE:688468) news
Chemclin Diagnostics Co., Ltd. Class A news releases on 6ix. Latest, Sep 4, 2026: "CHEMCLIN DIAGNOSTICS CO., LTD."Announcement on Participating in the 2026…
Press releases & updates
"CHEMCLIN DIAGNOSTICS CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Medical Device and Medical Equipment Industry
September 3, 2026
"CHEMCLIN DIAGNOSTICS CO., LTD."Semi-annual Report for 2026
August 27, 2026
"CHEMCLIN DIAGNOSTICS CO., LTD."Announcement on Adjustment of Core Technical Personnel
August 10, 2026
"CHEMCLIN DIAGNOSTICS CO., LTD."Announcement on Results of Shareholding Reduction by Shareholders Holding More Than 5% of the Shares
July 31, 2026
"CHEMCLIN DIAGNOSTICS CO., LTD."Indicative Announcement on the Change in Equity Interests of a Shareholder Holding More Than 5% of the Company's Shares to Below 5%
July 16, 2026
Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
June 2, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 20, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 8, 2026
Notice on Convening the 2025 Annual General Meeting
April 28, 2026
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by the Company
April 19, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Earnings Preannouncement for 2025
January 28, 2026
Report for Q3 2025
October 29, 2025
Announcement on Attending the Semi-annual Collective Performance Briefing for Medical Device and Equipment Companies on SSE STAR Market 2025
September 9, 2025
Announcement on Completing Term Change and Election of the Board of Directors and Appointing Senior Management Members and Securities Affairs Representative
September 5, 2025
Special Report on Semi-annual Deposit and Use of Raised Funds in 2025
August 29, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025
August 20, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 5, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 19, 2025
Announcement on Amending the Articles of Association and Some Governance Systems
April 28, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on the Completion of Share Reduction Plan and Reduction Results for Shareholders with Over 5% Shares
December 19, 2024
Indicative Announcement on Shareholding of Shareholders with Over 5% of Shares Reduced to Less Than 5%
December 2, 2024
Announcement on Implementation Results of Share Repurchase
November 27, 2024
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1%
November 19, 2024
Announcement on Progress in Repurchasing Shares through Call Auction
October 31, 2024
Announcement on Resolution of 11th Meeting of 2nd Board of Supervisors
October 29, 2024
Announcement on Result of Litigation
October 11, 2024
Announcement on the Expiration of Share Reduction Plan for Shareholders Over 5% Shareholding and Result of Shareholding Reduction
September 12, 2024
Announcement on Participation in the 2024 Semi-annual Special Collective Performance Briefing for Medical Devices and Medical Equipment in STAR Market
September 9, 2024
Announcement on Resolution of the 10th Meeting of the 2nd Board of Supervisors
August 29, 2024
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 5%
August 14, 2024
Announcement on Progress in Repurchasing Shares through Auction
July 31, 2024
"Corporate Value and Return Enhancement" Action Plan 2024
June 26, 2024
Announcement on Progress in Litigation
June 11, 2024
Announcement on Implementation of Dividend Distribution for 2023
June 5, 2024
Announcement on Resolutions of 2023 Annual General Meeting
May 22, 2024
Announcement on Plan of Shareholding Reduction by Shareholders with Over 5% Shares
May 20, 2024
Announcement on Attending Pharmaceutical Special Session of 2023 Annual Collective Performance Meeting of STAR Market and 2024 1st Quarter Performance Meeting
May 10, 2024
Special Report on Storage and Use of Raised Funds in 2023
April 29, 2024
Announcement on Circulation of Some Restricted Shares in Initial Public Offering
March 28, 2024
Announcement on Postponing Some Investment Projects Financed by Raised Funds
March 26, 2024
Announcement on Vesting Result in 1st Vesting Period of Initially Granted Part in Restricted Shares Incentive Plan of 2021 and Shares Listing
March 11, 2024
Announcement on 2023 Annual Preliminary Earnings Estimate
February 28, 2024
Announcement on Resolutions of 1st Special Shareholders' Meeting of 2024
February 26, 2024
Announcement on By-election of Non-independent Director
February 6, 2024